Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma

Esophageal cancer is a major health hazard in many parts of the world and is often diagnosed late. The objective of this study was to explore the efficacy and safety of nanoparticle albumin-bound paclitaxel (Nab-PTX) combined with cisplatin (DDP) in patients with metastatic esophageal squamous cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yan, Qin, Rui, Wang, Zhi-Kuan, Dai, Guang-Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668960/
https://www.ncbi.nlm.nih.gov/pubmed/23737672
http://dx.doi.org/10.2147/OTT.S44406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668960/
https://www.ncbi.nlm.nih.gov/pubmed/23737672
http://dx.doi.org/10.2147/OTT.S44406

Ejemplares similares